BELGRADE, Mont., July 1 /PRNewswire/ -- Bacterin International, Inc. (OTC Bulletin Board: KKTZ) ("Bacterin"), a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has confirmed the appointment of three seasoned financial experts to its Board of Directors. The three appointments include Daniel R. Frank whose asset management experience spans 31 years with particular focus on the healthcare industry and has served on several public and private Boards of Directors; Gary M. Simon, who has served as CFO for two NASDAQ listed companies and has managed investment money for over a decade; and Ken Calligar, who has over 25 years of executive management experience in corporate finance and capital markets.
Commenting on the board appointments, Guy Cook, Bacterin's founder and CEO, said, "Danny, Gary and Ken bring a wealth of knowledge and wisdom to Bacterin and have a vested interest in contributing to the company's success, as each have participated in our recent financing." Our Company produces biologics that are proprietary, highly effective, FDA approved, fully reimbursed by insurance companies and have the potential to be industry changing. We now have the financial talent inside our Company and on the Board to provide us with a solid foundation upon which we can build a rapidly growing revenue base. Their understanding of successful, emerging, growth companies, the capital markets and, in Danny's case, the healthcare industry will be an invaluable component to our board as we execute our strategy to elevate Bacterin to the next level."
Daniel R. Frank, who joins the Bacterin Board
|SOURCE Bacterin International, Inc.|
Copyright©2010 PR Newswire.
All rights reserved